Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Capromab Pendetide

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aytu BioScience Announces Closing of $12,000,000 Public Offering
    Aytu BioScience Announces Closing of $12,000,000 Public Offering

    06 Mar 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aytu-bioscience-announces-closing-of-12000000-public-offering-300609204.html

    PR NEWSWIRE
    06 Mar 2018
    Share Share
    Aytu BioScience Enters $2 Billion Testosterone Replacement Market with Acquisition of U.S. Rights to Natesto
    Aytu BioScience Enters $2 Billion Testosterone Replacement Market with Acquisition of U.S. Rights to Natesto

    26 Apr 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/aytu-bioscience-enters-2-billion-testosterone-replacement-market-with-acquisition-of-us-commercial-rights-to-natesto-300256563.html

    PR NEWSWIRE
    26 Apr 2016
    Share Share